Treatment of molluscum contagiosum and herpes simplex virus cutaneous infections

Cutis

Volumn 79, Issue 4 SUPPL., 2007, Pages 11-17

  Jones, Shay ^a   Kress, Douglas ^b  

^a Children's Dermatology Services   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX; HUMAN; MOLLUSCUM CONTAGIOSUM; REVIEW; TREATMENT OUTCOME;

HERPES SIMPLEX; HUMANS; MOLLUSCUM CONTAGIOSUM; TREATMENT OUTCOME;

EID: 34248338345     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Brown J, Janniger CK, Schwartz RA, et al. Childhood molluscum contagiosum. Int J Dermatol. 2006;45:93-99.
2. Saez M, Rodriguez-Martin M, Carnerero A, et al. Atypical molluscum contagiosum. J Eur Acad Dermatol Venereol. 2006;20:465-466.
3. Zaballos P, Ara M, Puig S, et al. Dermoscopy of molluscum contagiosum: as useful tool for clinical diagnosis in adulthood. J Eur Acad Dermatol Venereol. 2006;20:482-483.
4. Mandel MJ, Lewis RJ. Molluscum contagiosum of the newborn. Br J Dermatol. 1971;84:370-372.
5. van der Wouden JC, Menke J, Gajadin S, et al. Interventions for cutaneous molluscum contagiosum. Cochrane Database of Systematic Reviews [serial online]. 2007;1. Available from: John Wiley and Sons, Ltd; Hoboken, NJ. Accessed February 5, 2007.
6. Choong KY, Roberts LJ. Molluscum contagiosum, swimming and bathing: a clinical analysis. Australas J Dermatol. 1999;40:89-92.
7. Dohil MA, Lin P, Lee J, et al. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. 2006;54:47-54. Epub 2005 Nov 21.
8. Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. a review of twenty-seven patients. J Am Acad Dermatol. 1992;27:583-588.
9. Epstein WL. Molluscum contagiosum. Semin Dermatol. 1992;11:184-189.
10. Euvrard S, Kanitakis J, Cochat P, et al. Skin disease in children with organ transplants. J Am Acad Dermatol. 2001;44:932-939.
11. Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. 2000;43:503-507.
12. Becker TM, Blount JH, Douglas J, et al. Trends in molluscum contagiosum in the United States, 1966-1983. Sex Transm Dis. 1986;13:88-92.
13. Koning S, Bruijnzeels MA, van Suijlekom-Smit LW, et al. Molluscum contagiosum in Dutch general practice. Br J Gen Pract. 1994;44:417-419.
14. Silverberg NB. Pediatric molluscum contagiosum: optimal treatment strategies. Pediatr Drugs. 2003;5:505-512.
15. Weller R, O'Callaghan CJ, MacSween RM, et al. Scarring molluscum contagiosum: comparison of physical expression and phenol ablation. BMJ. 1999;319:1540.
16. Redmond RM. Molluscum contagiosum is not always benign. BMJ. 2004;329:403.
17. Cordoro KM, Ganz JE. Training room management of medical conditions: sports dermatology. Clin Sports Med. 2005;24:565-598, viii-ix.
18. Theos AU, Cummins R, Silverberg NB, et al. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis. 2004;74:134-138, 141-142.
19. Short KA, Fuller LC, Higgins EM. Double-blind, randomized, placebo-controlled trial of the use of topical 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Pediatr Dermatol. 2006;23:279-281.
20. Leslie KS, Dootson G, Sterling JC. Topical salicylic acid gel as a treatment for molluscum contagiosum in children. J Dermatolog Treat. 2005;16:336-340.
21. Kakourou T, Zachariades A, Anastasiou T, et al. Molluscum contagiosum in Greek children: a case series. Int J Dermatol. 2005;44:221-223.
22. Hanna D, Hatami A, Powell J, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol. 2006;23:574-579.
23. Syed TA, Goswami J, Ahmadpour OA, et al. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol. 1998;25:309-313.
24. Cunningham BB, Palier AS, Garzon M. Inefficacy of oral cimetidine for nonatopic children with molluscum contagiosum. Pediatr Dermatol. 1998;15:71-72.
25. Dohil M, Prendiville JS. Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients. Pediatr Dermatol. 1996;3:310-312.
26. Ross CL, Orchard DC. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients. Australas J Dermatol. 2004;45:100-102.
27. Hengge UR, Esser S, Schultewolter T, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol. 2000;143:1026-1031.
28. Liota E, Smith KJ, Buckley R, et al. Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg. 2000;4:76-82.
29. Barba AR, Kapoor S, Berman B. An open label safety study of topical imiquimod 5% cream in the treatment of molluscum contagiosum in children. Dermatol Online J. February 2001;7:20.
30. Skinner RB Jr. Treatment of molluscum contagiosum with imiquimod 5% cream. J Am Acad Dermatol. 2002;47(suppl 4):S221-S224.
31. Bayerl C, Feller G, Goerdt S. Experience in treating molluscum contagiosum in children with imiquimod 5% cream. Br J Dermatol. 2003;149(suppl 66):25-29.
32. Arican O. Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children. Pediatr Int. 2006;48:403-405.
33. Hengge UR, Cusini M. Topical immunomodulators for the treatment of external genital warts, cutaneous warts, and molluscum contagiosum. Br J Dermatol. 2003;149 (suppl 66):15-19.
34. Suzuki H, Wang B, Shivji GM, et al. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol. 2000;114:135-141.
35. Harrison CJ, Jenski L, Voychehovski T, et al. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection [published correction appears in Antiviral Res. 1989;11:215].
36. Antiviral Res. 1988;10:209-223.
37. Harrison CJ, Miller RL, Bernstein DI. Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine. Vaccine. 2001;19:1820-1826.
38. Schacker TW, Conant M, Thoming C, et al. Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study. Antimicrob Agents Chemother. 2002;46:3243-3248.
39. Bernstein DI, Spruance SL, Arora SS, et al. Evaluation of imiquimod 5% cream to modify the natural history of herpes lahialis: a pilot study. Clin Infect Dis. 2005;41:808-814. Epub 2005 Aug 10.
40. Gilbert J, Drehs MM, Weinberg JM. Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection. Arch Dermatol. 2001;137:1015-1017.
41. Danielsen AG, Petersen CS, Iversen J. Chronic erosive herpes simplex infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir. Br J Dermatol. 2002;147:10.34-10.36.
42. Brummitt CF. Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes. Clin Infect Dis. 2006;42:575.